Guangdong Marubi Biotechnology Co., Ltd. (SHA:603983)
China · Delayed Price · Currency is CNY 25.41
+0.24 (0.95%)
May 6, 2026, 3:00 PM CST
SHA:603983 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 213.21 | 247.24 | 341.63 | 259.42 | 174.18 | 247.92 |
Depreciation & Amortization | 60.01 | 60.01 | 28.31 | 24.56 | 26.53 | 20.08 |
Other Amortization | 3.98 | 3.98 | 1.43 | 1.13 | 10.82 | 13.32 |
Loss (Gain) From Sale of Assets | -0.38 | -0.38 | -0.03 | -0.52 | -0.31 | -0.42 |
Asset Writedown & Restructuring Costs | 0.26 | 0.26 | 0.31 | 0.07 | 0.03 | 0.1 |
Loss (Gain) From Sale of Investments | -27.99 | -27.99 | -19.04 | -114.62 | -32.82 | -25.28 |
Provision & Write-off of Bad Debts | -0.69 | -0.69 | 0.04 | -2.42 | 2.14 | 1.33 |
Other Operating Activities | 106.41 | 7.61 | 22.67 | 37.84 | 6.24 | 4.38 |
Change in Accounts Receivable | 54.37 | 54.37 | -41.38 | -12.4 | -72.9 | -114.01 |
Change in Inventory | -16.98 | -16.98 | -60.16 | -33.08 | -25.21 | -13.96 |
Change in Accounts Payable | -36.55 | -36.55 | 61.91 | 184.7 | -22.09 | -150.3 |
Change in Other Net Operating Assets | - | - | 0.54 | - | -0.12 | 0.09 |
Operating Cash Flow | 338.66 | 273.88 | 300.53 | 338.02 | 48.44 | -7.48 |
Operating Cash Flow Growth | 19.72% | -8.87% | -11.09% | 597.88% | - | - |
Capital Expenditures | -213.57 | -205.25 | -316.37 | -254.05 | -110.91 | -117.14 |
Sale of Property, Plant & Equipment | 0.02 | 0.02 | 0 | 0 | 0.02 | 0.01 |
Cash Acquisitions | - | - | - | - | 0 | 0 |
Divestitures | 0.23 | 0.12 | 3.2 | - | 8.99 | 2.03 |
Investment in Securities | -76.34 | -117.87 | 736.01 | 6.76 | 169.51 | -572.79 |
Other Investing Activities | -40.55 | 9.04 | 9.35 | 32.12 | 2.53 | 6.76 |
Investing Cash Flow | -330.21 | -313.94 | 432.19 | -215.16 | 70.14 | -681.14 |
Short-Term Debt Issued | - | - | 150 | 100 | - | - |
Long-Term Debt Issued | - | - | - | - | 150 | - |
Total Debt Issued | - | - | 150 | 100 | 150 | - |
Short-Term Debt Repaid | - | -150 | -248 | -2 | - | -106.56 |
Long-Term Debt Repaid | - | -959.64 | -4.4 | -109.33 | -9.29 | -4.44 |
Total Debt Repaid | -959.64 | -1,110 | -252.4 | -111.33 | -9.29 | -111 |
Net Debt Issued (Repaid) | -959.64 | -1,110 | -102.4 | -11.33 | 140.71 | -111 |
Issuance of Common Stock | - | - | - | - | - | 25.86 |
Repurchase of Common Stock | - | - | - | -13.07 | -8.88 | -4.35 |
Common Dividends Paid | -300.75 | -300.89 | -313.16 | -106.11 | -76.77 | -141.92 |
Other Financing Activities | 800.5 | 812.79 | 222.41 | -14.8 | 89.87 | 61.56 |
Financing Cash Flow | -459.89 | -597.73 | -193.15 | -145.31 | 144.92 | -169.84 |
Foreign Exchange Rate Adjustments | -0.04 | -0.01 | -0.05 | 0.01 | -0.03 | -0.02 |
Net Cash Flow | -451.48 | -637.8 | 539.52 | -22.44 | 263.46 | -858.48 |
Free Cash Flow | 125.09 | 68.63 | -15.85 | 83.98 | -62.47 | -124.62 |
Free Cash Flow Margin | 3.58% | 1.98% | -0.53% | 3.77% | -3.61% | -6.97% |
Free Cash Flow Per Share | 0.31 | 0.17 | -0.04 | 0.21 | -0.15 | -0.31 |
Cash Income Tax Paid | 259.49 | 267.99 | 257 | 238.25 | 262.56 | 250.59 |
Levered Free Cash Flow | -90.14 | 40.31 | -111.53 | 64.76 | -80.21 | -182.58 |
Unlevered Free Cash Flow | -88.09 | 42.36 | -105.37 | 68.9 | -78.19 | -181.94 |
Change in Working Capital | -16.16 | -16.16 | -74.8 | 132.57 | -138.37 | -268.91 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.